Nextech Invest Ltd.
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Nextech Invest Ltd. reported 15 stock positions worth $430.3 million. Its top holding was Revolution Medicines (RVMD) at 62.5% of the portfolio, followed by Tyra Biosciences (TYRA, 8.8%) and Oric Pharmaceuticals (ORIC, 6.9%).
- Most Recent 13F
- Q2 2026
- Location
- Zurich, V8
- CIK
- 0001595430
- Portfolio Value
- $430.3M (Q1 2025)
- SEC Filing
- 0001415889-25-013146 ↗ filed May 15, 2025
Holdings Value
Holdings 15 stocks · $430.3M
| RVMD Revolution Medicines Inc. | 62.46% | 7,601,087 | $268.8M | — |
| TYRA Tyra Biosciences Inc. | 8.77% | 4,055,861 | $37.7M | — |
| ORIC Oric Pharmaceuticals Inc. | 6.85% | 5,285,714 | $29.5M | — |
| ZYME Zymeworks Inc. | 3.08% | 1,113,946 | $13.3M | — |
| SPRY Ars Pharmaceuticals Inc. | 2.74% | 936,729 | $11.8M | — |
| CRGX Cargo Therapeutics Inc. | 2.50% | 2,642,502 | $10.8M | — |
| RLAY Relay Therapeutics Inc. | 2.34% | 3,846,409 | $10.1M | — |
| ARVN Arvinas Inc. | 2.30% | 1,408,394 | $9.9M | — |
| ALMS Alumis Inc. | 2.11% | 1,476,998 | $9.1M | — |
| CGEM Cullinan Therapeutics Inc. | 2.01% | 1,141,145 | $8.6M | — |
| TNGX Tango Therapeutics Inc. | 1.76% | 5,533,980 | $7.6M | — |
| CNTX Context Therapeutics Inc. | 1.06% | 7,419,355 | $4.5M | — |
| MERSANA THERAPEUTICS INC | 0.97% | 12,067,246 | $4.2M | — |
| SLN Silence Therapeutics PLC-ADR | 0.62% | 952,400 | $2.7M | — |
| BOLD Boundless Bio Inc. | 0.43% | 1,228,069 | $1.9M | — |
Portfolio Sells Q1 2025
No earlier filing to compare with.
Portfolio Buys Q1 2025
No earlier filing to compare with.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 15 | $2.1B | RVMD, PBLS, RLAY, TYRA, ALMS |
| Q1 2026 | 17 | $1.4B | RVMD, TYRA, TNGX, ORIC, ALMS |
| Q4 2025 | 16 | $1.0B | RVMD, TYRA, TNGX, ORIC, RLAY |
| Q3 2025 | 15 | $657.0M | RVMD, ORIC, TYRA, TNGX, RLAY |
| Q2 2025 | 16 | $528.4M | RVMD, ORIC, TYRA, TNGX, KYMR |
| Q1 2025 | 15 | $430.3M | RVMD, TYRA, ORIC, ZYME, SPRY |